Amneal to Participate at Upcoming Investor Conferences in June

Company Overview - Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company headquartered in Bridgewater, NJ, focusing on the development, manufacturing, and distribution of over 280 pharmaceuticals primarily in the United States [2] - The company operates in multiple segments, including Affordable Medicines, Specialty, and AvKARE, with a diverse portfolio that includes complex product categories such as injectables and biosimilars, as well as branded pharmaceuticals targeting central nervous system and endocrine disorders [2] Upcoming Events - Amneal Pharmaceuticals will participate in the Jefferies Global Healthcare Conference on June 5, 2025, with a company presentation scheduled for 9:20 AM ET [1] - The company will also take part in the Goldman Sachs Global Healthcare Conference on June 10, 2025, featuring a fireside chat at 10:40 AM ET [1] - Key executives, including Co-CEO Chirag Patel and CFO Tasos Konidaris, will represent the company at both conferences [1]